https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-ar/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-ru/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/longer-persistence-seen-with-upadacitinib-versus-tnfi-in-rheumatoid-arthritis-id/ 2026-07-11T06:34:50+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-fr/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-zh-tw/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-fr/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-de/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ja/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-pt/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-es/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ar/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ru/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-id/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-th/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-vi/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-id/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/krystal-10-at-esmo-gi-2026-adagrasib-plus-cetuximab-vs-chemotherapy-in-kras-g12c-mutated-mcrc-oncodaily-ms/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-th/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-vi/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-zh-tw/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/pembrolizumab-belzutifan-tied-to-improved-disease-free-survival-in-renal-cell-carcinoma-ms/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-en/ 2026-07-11T06:34:49+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-de/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ja/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-pt/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-es/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ar/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ru/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-id/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-th/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-vi/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%f0%9f%8e%89%e3%80%90%e8%af%ba%e5%8d%8e%e6%b3%b0%e8%8f%b2%e4%b9%90%e8%81%94%e5%90%88%e8%bf%88%e5%90%89%e5%ae%81%e8%8e%b7%e6%89%b9%e6%96%b0%e9%80%82%e5%ba%94%e7%97%87%e3%80%91-%e9%87%91-ms/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-zh/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-en/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-fr/ 2026-07-11T06:34:48+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ja/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-pt/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-es/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ar/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ru/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-id/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-th/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-vi/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-ms/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-zh-tw/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-fr/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-de/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ja/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/%e3%80%8c%e5%b0%91%e9%9d%b6%e7%9c%9f%e6%8e%a2%e8%90%a5%e3%80%8dpfs-%e8%b6%8518-%e4%b8%aa%e6%9c%88%ef%bc%81%e8%be%be%e6%8b%89%e9%9d%9e%e5%b0%bc-%e6%9b%b2%e7%be%8e%e6%9b%bf%e5%b0%bc%e4%ba%8c%e7%ba%bf-de/ 2026-07-11T06:34:47+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ar/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-th/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ru/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-vi/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-id/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-th/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-vi/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-ms/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-zh-tw/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-fr/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-de/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ja/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-pt/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-es/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ar/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-pt/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ru/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dabrafenib-plus-trametinib-in-brafv600e-mutated-rare-cancers-the-phase-2-roar-trial-nature-es/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-id/ 2026-07-11T06:34:46+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-zh-tw/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/dr-fakih-on-the-fda-approval-of-sotorasib-plus-panitumumab-for-kras-g12c-mutated-mcrc-onclive-ms/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-fr/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-de/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-zh-tw/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ja/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-fr/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-pt/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-de/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ja/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-pt/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-es/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ar/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ru/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-id/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-th/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-vi/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/lumakras-sotorasib-in-combination-with-vectibix-panitumumab-fda-approved-for-metastatic-colorectal-cancer-with-kras-g12c-mutation-news-cancerconnect-com-ms/ 2026-07-11T06:34:45+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-de/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-ja/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-pt/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-es/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-ar/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-ru/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-es/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-id/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ar/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-th/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ru/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-vi/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-id/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-ms/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-th/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-vi/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approves-sotorasib-lumakras-combination-for-metastatic-colorectal-cancer-oncology-news-central-ms/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-zh-tw/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/fda-approval-of-acalabrutinib-plus-venetoclax-brings-an-all-oral-fixed-duration-option-to-frontline-cll-care-onclive-fr/ 2026-07-11T06:34:44+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-es/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-ar/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-ru/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-id/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-th/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-vi/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-ms/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-zh-tw/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-en/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-fr/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-zh-tw/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-de/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-fr/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-ja/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-de/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-ja/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/mitotane-market-growth-and-status-explored-in-a-new-research-openpr-com-pt/ 2026-07-11T06:34:43+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-ru/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-id/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-th/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-vi/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-ms/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-zh/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-en/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-fr/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-pt/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-es/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/%e6%81%92%e7%91%9e%e5%8c%bb%e8%8d%af%e6%8a%ab%e9%9c%b2%e5%8f%a3%e6%9c%8d%e5%b0%8f%e5%88%86%e5%ad%90glp-1%e5%8f%97%e4%bd%93%e6%bf%80%e5%8a%a8%e5%89%82hrs-7535%e7%ac%ac%e4%ba%8c%e9%a1%b9%e4%b8%ad-ar/ 2026-07-11T06:34:42+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-th/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-vi/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-ms/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-zh-tw/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-en/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-fr/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-de/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-ja/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-pt/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-es/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-ar/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-ru/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/mira-pharmaceuticals%e8%a1%a8%e7%a4%ba%ef%bc%8cskny-1%e5%9c%a8%e8%82%a5%e8%83%96%e7%97%87%e5%92%8c%e6%88%90%e7%98%be%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e4%b8%b4%e5%ba%8a%e5%89%8d%e7%a0%94%e7%a9%b6-id/ 2026-07-11T06:34:41+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ms/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-zh/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-en/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-fr/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-de/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ja/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-pt/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-es/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ar/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ru/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-id/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-th/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-vi/ 2026-07-11T06:34:40+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-zh-tw/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-en/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-fr/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-de/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ja/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-pt/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-es/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ar/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ru/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-id/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-th/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-vi/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b01672-hk%e5%90%91%e7%be%8e%e5%9b%bdfda%e9%80%92%e4%ba%a4%e4%b8%a4%e9%a1%b9%e6%b2%bb%e7%96%97%e8%82%a5%e8%83%96%e7%97%87%e7%9a%84ind%e7%94%b3%e8%af%b7%ef%bc%9a-ms/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8/ 2026-07-11T06:34:39+00:00 https://keshavmed.com/news/%e7%a4%bc%e6%9d%a5%e8%82%a1%e4%bb%b7%e4%b8%8a%e6%b6%a84-5%ef%bc%8c%e8%82%a5%e8%83%96%e7%97%87%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e6%95%b0%e6%8d%ae%e4%ba%ae%e7%9b%b8%e5%ad%a6%e6%9c%af%e4%bc%9a-fr/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-de/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-ja/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-pt/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-es/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-ar/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-ru/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-id/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-th/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-vi/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e6%ad%8c%e7%a4%bc%e5%88%b6%e8%8d%af-b%e5%ae%a3%e5%b8%83%e5%85%b6%e6%af%8f%e6%9c%88%e4%b8%80%e6%ac%a1%e7%9a%ae%e4%b8%8b%e6%b3%a8%e5%b0%84glp-1r-gipr%e5%8f%8c%e9%9d%b6%e7%82%b9%e6%bf%80%e5%8a%a8-ms/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e7%a4%bc%e6%9d%a5%e8%82%a1%e4%bb%b7%e4%b8%8a%e6%b6%a84-5%ef%bc%8c%e8%82%a5%e8%83%96%e7%97%87%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e6%95%b0%e6%8d%ae%e4%ba%ae%e7%9b%b8%e5%ad%a6%e6%9c%af%e4%bc%9a/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e7%a4%bc%e6%9d%a5%e8%82%a1%e4%bb%b7%e4%b8%8a%e6%b6%a84-5%ef%bc%8c%e8%82%a5%e8%83%96%e7%97%87%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e6%95%b0%e6%8d%ae%e4%ba%ae%e7%9b%b8%e5%ad%a6%e6%9c%af%e4%bc%9a-zh-tw/ 2026-07-11T06:34:38+00:00 https://keshavmed.com/news/%e7%a4%bc%e6%9d%a5%e8%82%a1%e4%bb%b7%e4%b8%8a%e6%b6%a84-5%ef%bc%8c%e8%82%a5%e8%83%96%e7%97%87%e6%96%b0%e8%8d%af%e4%b8%b4%e5%ba%8a%e6%95%b0%e6%8d%ae%e4%ba%ae%e7%9b%b8%e5%ad%a6%e6%9c%af%e4%bc%9a-en/ 2026-07-11T06:34:38+00:00